BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22492732)

  • 21. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
    Bütof R; Hofheinz F; Zöphel K; Stadelmann T; Schmollack J; Jentsch C; Löck S; Kotzerke J; Baumann M; van den Hoff J
    J Nucl Med; 2015 Aug; 56(8):1150-6. PubMed ID: 26089549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
    Nguyen TV; Yueh B
    Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
    Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
    J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
    Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J
    Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.
    Shah B; Srivastava N; Hirsch AE; Mercier G; Subramaniam RM
    Ann Nucl Med; 2012 Nov; 26(9):707-14. PubMed ID: 22797818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
    Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
    Eur J Radiol; 2015 Jun; 84(6):1171-6. PubMed ID: 25816993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
    Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
    J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of Intratumoral Metabolic Heterogeneity and Quantitative
    Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
    AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma.
    Lacy PD; Spitznagel EL; Piccirillo JF
    Cancer; 1999 Oct; 86(8):1387-95. PubMed ID: 10526264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma.
    Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT
    Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma.
    Choi WR; Oh JS; Roh JL; Kim JS; Oh I; Choi SH; Nam SY; Kim SY
    Head Neck; 2019 Jun; 41(6):1846-1853. PubMed ID: 30675738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
    Sasaki R; Komaki R; Macapinlac H; Erasmus J; Allen P; Forster K; Putnam JB; Herbst RS; Moran CA; Podoloff DA; Roth JA; Cox JD
    J Clin Oncol; 2005 Feb; 23(6):1136-43. PubMed ID: 15718309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
    Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
    J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.
    Baek CH; Chung MK; Son YI; Choi JY; Kim HJ; Yim YJ; Ko YH; Choi J; Cho JK; Jeong HS
    J Nucl Med; 2008 Sep; 49(9):1422-8. PubMed ID: 18703597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.